• Users Online: 724
  • Print this page
  • Email this page
  • Email this page
  • Email this page
  • Email this page

    Article Cited by others


Sparing of injection sites in patients with extensive psoriasis treated with various biologics

Tsai Ya-Chu, Tsai Tsen-Fang

Year : 2019| Volume: 37| Issue : 2 | Page no: 90-92

   This article has been cited by
1 A case of erythrodermic psoriasis in which adalimumab injection sites are preserved
Ilknur Ozcan,Ayse Serap Karadag,Eylem Ceren,Busra Demirci,Filiz Cebeci
Dermatologic Therapy. 2021;
[Pubmed]  [Google Scholar] [DOI]
2 Classification and mitigation of negative injection experiences with biologic medications
Jennifer M. Fernandez,Steven Madsen,Jeffrey M. Krase,Vivian Y. Shi
Dermatologic Therapy. 2020;
[Pubmed]  [Google Scholar] [DOI]
3 Clinical Features and Genetic Polymorphism in Chinese Patients with Erythrodermic Psoriasis in a Single Dermatologic Clinic
Yang Lo,Hsien-Yi Chiu,Tsen-Fang Tsai
Molecular Diagnosis & Therapy. 2019;
[Pubmed]  [Google Scholar] [DOI]
4 Improvement of recalcitrant psoriatic lesions on the lower legs by changing the injection site of secukinumab from the abdomen to lower legs
Kosuke Katsuo,Tetsuya Honda,Kenji Kabashima
The Journal of Dermatology. 2019;
[Pubmed]  [Google Scholar] [DOI]


Read this article